We have karyotyped a total of twelve ependymomas using GTG-banding including seven for which preliminary results have already been published. One case showing hyperdiploid main line with two marker chromosomes was further analyzed by nonisotopic chromosome in situ suppression hybridization. It was shown that the marker chromosomes consisted of 1q, 14q and 1q, and 22q. The possible role of chromosome 22 in ependymomas and the usefulness of fluorescence in situ hybridization for cytogenetic analysis in tumor investigation are discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0165-4608(94)00148-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neurofibromatosis type 2-related schwannomatosis - An update.
Semin Pediatr Neurol
December 2024
Department of Pediatric Neurosciences, University of Texas at Austin, Ascension Dell Children's Medical Center, USA.
Article Synopsis
- - Neurofibromatosis type 2-related schwannomatosis (NF2-SWN) is a genetic disorder caused by mutations in the NF2 gene, affecting about 1 in 50,000 people globally, leading to the development of various tumors in the central nervous system.
- - The condition is characterized by the occurrence of bilateral vestibular schwannomas in over 95% of patients, along with other tumors such as meningiomas and gliomas, as well as potential eye issues.
- - Early detection through thorough medical exams is crucial for managing NF2-SWN, and most patients benefit from a combination of treatments, including surgery.
Case report: Polymorphous low-grade neuroepithelial tumor of the young and supratentorial ependymoma diagnosed in an adult male.
Front Neurol
November 2024
Division of Neurology, McMaster University, Hamilton, ON, Canada.
Polymorphous low-grade neuroepithelial tumor of the young (PLNTY) is a rare central nervous system (CNS) pathology predominantly observed in the pediatric population. Ependymomas also exhibit a peak incidence in early childhood, with rare presentations after early adulthood. In this report, we describe a rare case of a 41-year-old man diagnosed sequentially with a polymorphous low-grade neuroepithelial tumor of the young, followed by a supratentorial ependymoma within a year.
View Article and Find Full Text PDFA primary intracranial neuroepithelial neoplasm with novel TCF3::BEND2 fusion: a case report.
Acta Neuropathol Commun
November 2024
Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Astroblastoma, MN1-altered, is a rare circumscribed glial neoplasm that is composed of round, cuboidal, orcolumnar cells with astroblastic perivascular pseudorosettes, often associated with MN1::BEND2 and MN1::CXXC5 fusions. Atroblastoma-like gliomas harbouring EWSR1::BEND2 have been reported that they defined an epigenetically distinct subtype of astroblastoma. We report a case of a 19-year-old female with an intracranial neuroepithelial tumor featuring a novel TCF3::BEND2 fusion.
View Article and Find Full Text PDFH3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications.
Cancers (Basel)
October 2024
Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, 95123 Catania, Italy.
Central nervous system (CNS) tumors represent a formidable clinical challenge due to their molecular complexity and varied prognostic outcomes. This review delves into the pivotal role of the epigenetic marker H3K27me3 in the development and treatment of CNS tumors. H3K27me3, specifically the trimethylation of lysine 27 on the histone H3 protein, plays a crucial role in regulating gene expression and maintaining chromatin architecture (e.
View Article and Find Full Text PDFConcurrent ependymal and ganglionic differentiation in a subset of supratentorial neuroepithelial tumors with EWSR1-PLAGL1 rearrangement.
Acta Neuropathol Commun
September 2024
Department of Pathology, Neuropathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA.
Neuroepithelial tumors with fusion of PLAGL1 or amplification of PLAGL1/PLAGL2 have recently been described often with ependymoma-like or embryonal histology respectively. To further evaluate emerging entities with PLAG-family genetic alterations, the histologic, molecular, clinical, and imaging features are described for 8 clinical cases encountered at St. Jude (EWSR1-PLAGL1 fusion n = 6; PLAGL1 amplification n = 1; PLAGL2 amplification n = 1).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!